RecruitingNot ApplicableNCT05558566

Neurofeedback From the Supplementary Motor Area for Tourette Syndrome


Sponsor

Yale University

Enrollment

64 participants

Start Date

Nov 1, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

This is a clinical trial where adolescents aged 10-16 years old with Tourette Syndrome (or chronic tic disorder) are randomized to receive either real-time functional magnetic resonance imaging (fMRI) neurofeedback targeting the supplementary motor area (for the experimental intervention) or real-time fMRI neurofeedback (NF) from a control region (for the control intervention).


Eligibility

Min Age: 10 YearsMax Age: 16 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Neurofeedback from control region and Neurofeedback from the SMA for people with tourette syndrome in adolescence. The study is currently recruiting participants at 1 location. People eligible for this study include aged 10 Years to 16 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERNeurofeedback from the SMA

Feedback is provided regarding activity in the SMA and participant attempts to control SMA activity using the feedback as a training signal

OTHERNeurofeedback from control region

Feedback is provided regarding activity in a control region and participant attempts to control activity in that region using the feedback as a training signal.


Locations(1)

Yale University School of Medicine

New Haven, Connecticut, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05558566


Related Trials